Method Development and Validation for Nutraceuticals
|
|
- Dwain Todd
- 6 years ago
- Views:
Transcription
1 White Paper Method Development and Validation for Nutraceuticals Maud Silvent Technical Specialist David Neville Technical Specialist
2 Method Development and Validation for Nutraceuticals Introduction Nutraceutical is a term formed from the amalgamation of the words pharmaceutical and nutrition by Dr Stephen Felice in Others have since tried to further define the term to distinguish and clarify the difference between functional foods, dietary supplements and nutraceuticals. There is now some consensus that a nutraceutical can be loosely defined as a functional food or supplement that aids in the prevention or alleviation of a disease state or disorder (except for anaemia), and not just supplement the diet. Therefore, a nutraceutical may be incorporated into a food product/matrix, or into a pill, capsule, tablet etc. There is no strict legal definition in the US, Canada or Europe to define nutraceutical, but other legal requirements do exist to cover dietary supplements and novel foods within these markets. Many of the compounds present in nutraceuticals that may possess beneficial health effects are derived from botanical sources, and will be considered to be natural in form. These products can be as diverse as proteins, peptides, lipids, flavonoids and isoflavanoids, polyphenols and tannins. Additionally, vitamins and minerals, sugar molecules such as glucosamine and chondroitin, may also be considered as nutraceuticals. Therefore, the range of nutraceuticals that require analysis is diverse, both in types of structures and matrices, and this is matched by the diversity of techniques and extraction conditions that need to be employed for accurate quantitation of the active nutraceutical of interest. It is also important to note that the purification, or not, of the nutraceutical from its natural matrix must also be considered as there may be contaminants/impurities/adulterants present that are deleterious to human health, or whose amounts are regulated by legislation (heavy metals, allergens, toxins). These must also be incorporated into a testing regime to ensure the safety of the product end-user. This article focuses on the analytical approaches that must be considered when performing a method development and validation exercise to ensure that your test method is fit-for-purpose, and meets the regulatory need of your nutraceutical of interest. The ultimate aim is to accurately quantify your nutraceutical of interest whether in final product matrix or as a raw material prior to incorporation into product. Due to the inherent complexity of many of the nutraceutical products that exist on the market, and to the complexity of the nutraceuticals themselves, there is no single analytical approach that can be undertaken. The extraction of the nutraceutical can be performed in a number of ways from simple liquid extraction into water or organic solvent, to more complex distillation procedures. This extraction is prior to final analytical procedures that may be HPLC- or GC-based with fluorescent, UV, mass spectrometric, refractive index, FID or other detection techniques. Additionally, ELISA, enzyme-based kits and chemical assays can be used. These assays are often separate from the type of testing regime that may be necessary to define the physicochemical properties of your product of interest. Therefore, the principles that must be followed to ensure the assay is accurate, precise, reproducible, and fit-for-purpose are outlined. Development of Assay At the outset of any method development and validation procedure it is important to understand the requirements of the assay, how the data will be used, who will perform the assay and where the assay will be employed. Factors such as in-line or near-line testing (quick and easy), experience of operator, QC/QA or NPD laboratory (robust), for regulatory submission, equipment capabilities, and method transfer will need to be considered. These findings will help in determining the best approach that can be taken to ensure that the method fulfils the business need. The experience of the laboratory concerned in analysing similar matrices, a comprehensive literature search to discover what is currently available (approved methods from AOAC, Pharmacopoeias, AACC and ISO, or published peer-reviewed articles) and the availability of appropriate standards can be investigated. Approved methods can form the basis of any new method that may be required, and are excellent starting points for development studies. As many of the analytical methods currently used are based on HPLC separation prior to detection by the most appropriate method for the nutraceutical of interest (UV, RI, Fluorescence, ELSD, MS etc.), this will be the focus of this article. However, the principles still apply to other types of analytical methods that Page 2
3 may be used, such as wet chemistry, colourimetric or enzyme-based. Following the initial scoping phase, development becomes a matter of experimentation to find the optimal analytical parameters, such as ph, extraction solution, mobile phase, type of liquid chromatography column, and retention time, for the method. The optimisation of each parameter will require careful attention to detail. This will ensure that maximum recovery of nutraceutical and accurate quantitation of the analyte of interest are achieved. Adequate time must be taken for each separate phase as these conditions will be used to determine the final, optimised and streamlined procedure in the next stage of the method validation. Additionally, it is the optimisation of each stage (see Figure 1) that ensures that progress through method validation is as easy as possible. It is important that the source and quality of reagents used, the supplier of the HPLC system (and model number of component parts) used, and instrument settings are specified within the method to ensure that the method can be reproduced by other operators and laboratories. Figure 1 HPLC method development single considerations It is important to note that method development and validation can be undertaken to analyse a component, but within a number of different matrices. As the nutraceutical may be incorporated into different product matrices, a decision must be made whether the development and validation is for one or multiple matrices. It is often better to develop and validate for multiple matrices rather than go through an extension-of-scope exercise. This, of course, is highly dependent on the initial product development cycle, and the amount of analytical time available to perform the necessary experiments. Validation of Assay Validation is defined by the International Organization for Standardisation (ISO) as verification, where the specified requirements are adequate for an intended use. Additionally, the term verification is defined as the confirmation by examination and the provision of objective evidence that the particular requirements for a specific intended use are fulfilled (ISO/IEC 17025:2005 cl ). The method validation starts only when the method parameters have been finalised as part of the method development. In majority of cases, a validation protocol will be written, and agreed upon by the relevant people (analyst, laboratory manager, QC/QA department, clients etc.), following the ICH guidelines that are routinely based on ISO guidelines. The acceptance criteria will be set using data generated during the method development stage but will also depend of the agreed compound specification tolerance. Additionally, as previously mentioned, the source and quality of reagents used, and the supplier of the HPLC system (and model number of component parts) used are defined. Final instrument settings that are optimal for the nutraceutical of interest (column temperature, eluent gradient conditions, and detector settings) are also defined, and used, as part of the validation exercise. It is important to note that not all laboratories are equipped with the same HPLC systems. Therefore, part of the validation may incorporate a study to test the equivalence of results using different HPLC systems (see reproducibility below). Why is it important to validate a method once it has been developed? The answer is to be confident in your results and to ensure the method is fit-for-purpose for that specific compound in that specific matrix. When would it be required? At any stage of discovery, development, and manufacture of pharmaceuticals or food products, but also to perform stability studies, and to submit a dossier for claim substantiation or novel food ingredient. For example, knowing the uncertainty of the method would give you an indication if a trend in stability results is genuine or not. The purpose of a method validation is to confirm that the method is specific, precise, accurate and robust. The level and extent of the validation will evolve with the Page 3
4 nutraceutical development phase. Typical method parameters recommended by FDA, USP, and ICH are as follows: Specificity, Linearity range Accuracy Method precision (incorporating method repeatability, intermediate precision and method reproducibility) Limit of detection (LOD) and limit of quantitation (LOQ) Solution stability Robustness Each parameter will give specific indication of the method performance, and each topic is covered in greater detail below. Specificity The specificity for the compound(s) of interest needs to be evaluated to understand the ability of the method parameters to separate any potential interferences coming from the sample matrix like other excipients, potential degradation products and the mobile phase. Ideally a placebo sample with the same ingredients/excipients but without the compound(s) of interest will be available to analyse to determine the specificity of the method. A forced degradation study can also be performed to artificially stress the product and obtain potential degradation compounds that could interfere with the analysis of the compound(s) of interest. Linearity The linearity will assess the proportional range of the method response, i.e. the concentration range over which the method can accurately determine the compound concentration. A minimum of five standard concentration levels, covering the concentration range in the final dilution of the sample matrix to be analysed, is recommended for investigation. In the case of a chromatography technique, the different standard solutions will be injected and analysed in ascending and descending order to assess if the method is affected by sample carryover into the next injection/analysis. It is also at this stage that the standardisation parameters (use of internal or external standards for accurate quantitation of analyte) are investigated. Accuracy The accuracy is the capability of an analytical method to determine the correct measurement, or exactness between a measured value and a theoretical value. The best approach is to work with certified reference materials (CRMs). However, those are not always available for the compound(s) of interest or for the specific matrix. Working with CRMs would increase the confidence in accessing the efficiency of the extraction procedure of the compound(s) of interest from the sample matrix. A second approach would be to spike the sample extraction solution with a known concentration of the compound(s) of interest and check how much is recovered. This approach will not investigate the efficiency of the extraction procedure on a sample embedded in a matrix, but only how the sample matrix may affect the spiked sample extraction procedures. Investigation of different levels of spiking is the best approach when CRMs are not available. It is important that the level of spiking should cover the concentration of the compound(s) of interest in your sample matrix over time. Figure 2 Precision and accuracy Precision The method repeatability is the ability of an analytical method to produce consistent results. The precision of a method is determined by its repeatability, intermediate precision, and reproducibility. A simplified diagram to illustrate accuracy and precision is shown in Figure 2. The repeatability will be measured to define the consistency of results when analysed by the same analyst, using the same instrument under the same analytical conditions. In most cases, it is assessed by preparing and analysing the same sample six to ten times. The percentage standard deviation will be assessed and compared to the acceptance criteria laid out in the validation protocol. The intermediate precision will be measured to define the consistency of results when samples are prepared and analysed by a second analyst using the same analytical conditions. Where possible, it is also best practice to perform the new analysis using a second column of the same specification as the first, and a second HPLC system (may or may not be the same manufacturer/model of HPLC system). This will evaluate the intra-laboratory precision. The percentage standard deviation will be assessed and compared to the acceptance criteria laid out in the validation protocol. The reproducibility evaluates the consistency of results between different laboratories or interlaboratory precision. It is worthwhile to note Page 4
5 that The International Conference for Harmonisation (ICH) addresses ruggedness as intermediate precision and reproducibility. The percentage standard deviation will be determined and compared to the acceptance criteria laid out in the validation protocol. The repeatability, intermediate precision, and reproducibility are used to determine the method uncertainty or relative uncertainty. Limit of Detection (LOD) and Limit of Quantitation (LOQ) The limit of detection (LOD) is commonly defined as the lowest concentration of the compound(s) of interest that can be detected under given method conditions using the defined instrument parameters. In chromatographic analysis a signal-to-noise (S/N) approach may be taken, where there is a detected baseline noise in the method. The LOD may be calculated as being of three times the signal-to-noise (S/N) ratio. This is, in essence, an instrumental detection limit. It is important to note that though the compound can be detected, it may not necessarily be within the linearity of the assay. Therefore, the parameter limit of quantitation must be defined. Figure 3 The relationship between LOQ, LOD and linear range of assay The limit of quantitation (LOQ) is the lowest concentration of the compound(s) of interest that can be accurately and precisely quantified under given method and conditions. The LOQ may be calculated as being the sample concentration that gives a ten times the signalto-noise ratio, and lies within the linear range of the assay. The relationship between LOQ, LOD and the linear range of the assay are illustrated in Figure 3. Solution Stability There may be times when samples cannot be immediately analysed, or there is a time delay between sample preparation and actual HPLC analysis, or prepared samples need to be reanalysed. Different conditions of temperature and times-of-storage of prepared samples and standards are assessed to determine if these are detrimental to sample quantitation. Robustness The robustness will assess the method ability to obtain consistent results when small variations in the analytical parameters are applied. The parameters under scrutiny could be column temperature, mobile phase concentration, flow rate, ph value, sample and standard solution stability, mobile phase stability, any other parameters specific to a particular technique that could change over time and could potentially affect the results. Control Once the method has been validated, it may be useful to perform continuous quality control on the assay to ensure that it is performing within specifications. Control (or Shewhart) charts are useful for large volume or continuous work. They require starting with at least values to calculate a mean and a standard deviation (SD), which form the basis for control values equivalent to the mean ± 2 * SD (warning limits) and the mean ± 3 * SD (rejection limits). At least one replicate test portion of a stable in-house reference material and a blank are run with every batch of test samples. The calculated mean and standard deviations (or range of replicates) of the controls are continuously assessed. These values are used for ongoing determination of warning and rejection limits. The analytical process is in control if not more than 5% of the values fall in the warning zone. Any value falling above the rejection limit or two consecutive values in the warning region requires investigation and corrective action. Additionally, trends in the values obtained can indicate that further investigation of the analytical method may be required. Challenges A major challenge for nutraceutical analysis in both method development and validation is the availability of standard or certified reference materials. In the case of a compound where no previous method exists, it can be difficult to obtain a reference material, or considerable cost can be incurred in synthesising reference material. Additionally, because the compounds of interest may be endogenous to a matrix Page 5
6 (such as a plant extract), the level of analyte often varies, depending on the agronomic conditions. Therefore, developing and optimizing methods for endogenous compounds usually requires a great deal of experimentation for the extraction and isolation phase of the method. Ensuring that all of the analytes of interest have been extracted from the matrix is critical for the analysis of complex matrices, such as processed foods. There is less difficulty where the compound of interest is embedded within clean matrices (tablet, capsule etc.) with known excipients. Considerable expense can be incurred when developing and validating new methods. This expense may be warranted where it can be foreseen that the method will be used for multiple samples over an extended time period. Both the business need, and return-oninvestment (ROI), must be taken into consideration when assessing the feasibility of developing and validating any new method. It is also worth noting that as instrumental technology and detection methods evolve, new methods may be necessary to meet the demands of speed and efficiency. Additionally, regulatory requirements may force the adaptation of new methods that are more sensitive, both in terms of compound determination and identification of impurities/adulterants within the sample matrices. Conclusion Method development and validation is necessary to ensure that the analytical procedures for a nutraceutical are fit-forpurpose, and can accurately quantify the compound of interest. The process can be time consuming and expensive, both in terms of man-hour and equipment/consumables costs. The work performed is carefully planned and must be documented at all stages to ensure that due process is followed. Once the method is developed, a validation protocol is agreed and, deviations from this procedure can occur unless agreed upon and approved by the relevant authorities. This does give some scope for limited further method development, but ideally this would be minimal. The purpose of the development phase is to try and ensure that the validation is performed using as close to as final a method as is possible. The validated final method can be specific for single or multiple matrices, but each matrix must be tested as part of the method development and validation exercise. Before the method can be put into routine use, the validation report must be issued and approved. Subsequently, the method can be transferred to the laboratory where appropriate training of personnel can be undertaken. When the required level of proficiency is attained, the method can be placed into routine use. David Neville Technical Specialist David is a Senior Associate Principal Scientist at Reading Scientific Services Ltd (RSSL). His expertise is in the analysis of sugars, carbohydrates, bioactive molecules and proteins in both food and biological matrices, and has published widely on these topics. Additionally, he has developed and validated a number of methods for detection of bioactive compounds within varied food matrices. Maud Silvent Technical Specialist Maud is a Senior Scientist at Reading Scientific Services Ltd (RSSL). Her expertise is in ion chromatographybased analysis of sugars in varied food matrices. Many of the analyses are novel and require, mostly performing method development and method validation. For further information, please contact Customer Services on enquiries@rssl.com Page 6
Analytical method validation. Presented by Debbie Parker 4 July, 2016
Analytical method validation Presented by Debbie Parker 4 July, 2016 Introduction This session will cover: Guidance and references The types of test methods Validation requirements Summary Slide 2 PharmOut
More informationJournal of Chemical and Pharmaceutical Research, 2013, 5(1): Research Article
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2013, 5(1):180-184 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 A simple and sensitive RP-HPLC method for estimation
More informationApplication Note. Agilent Application Solution Analysis of ascorbic acid, citric acid and benzoic acid in orange juice. Author. Abstract.
Agilent Application Solution Analysis of ascorbic acid, citric acid and benzoic acid in orange juice Application Note Author Food Syed Salman Lateef Agilent Technologies, Inc. Bangalore, India 8 6 4 2
More informationCHAPTER 2 SIMULTANEOUS DETRMINATION OF ANASTROZOLE AND TEMOZOLOMIDE TEMOZOLOMIDE CAPSULES 20 MG AND ANASTROZOLE TABLETS 1 MG
CHAPTER 2 SIMULTANEOUS DETRMINATION OF ANASTROZOLE AND TEMOZOLOMIDE IN TEMOZOLOMIDE CAPSULES 20 MG AND ANASTROZOLE TABLETS 1 MG ANALYTICAL METHOD VALIDATION REPORT FOR ASSAY 43 2.1 Introduction Analytical
More informationJournal of Chemical and Pharmaceutical Research
Available on line www.jocpr.com Journal of Chemical and Pharmaceutical Research ISSN No: 0975-7384 CODEN(USA): JCPRC5 J. Chem. Pharm. Res., 2011, 3(2):770-775 Validation of Rapid Liquid Chromatographic
More informationASSAY AND IMPURITY METHOD FOR DURACOR TABLETS BY HPLC
ASSAY AND IMPURITY METHOD FOR DURACOR TABLETS BY HPLC METHOD APPROVALS Norvin Pharma Inc. Author Analytical Laboratory Approver Analytical Laboratory Group Leader Approver Manager Quality Control Chemistry
More informationMETHOD DEVELOPMENT AND VALIDATION BY RP-HPLC FOR ESTIMATION OF ZOLPIDEM TARTARATE
WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Ramalakshmi et al. SJIF Impact Factor 6.647 Volume 7, Issue 2, 1010-1018 Research Article ISSN 2278 4357 METHOD DEVELOPMENT AND VALIDATION BY RP-HPLC
More informationChallenges of Incorporating Functional Ingredients into Foods - An NPD and Analytical Perspective
Challenges of Incorporating Functional Ingredients into Foods - An NPD and Analytical Perspective Jane Staniforth & Robert Griffiths Customer Focused, Science Driven, Results Led Overview Introduction
More informationF. Al-Rimawi* Faculty of Science and Technology, Al-Quds University, P.O. Box 20002, East Jerusalem. Abstract
JJC Jordan Journal of Chemistry Vol. 4 No.4, 2009, pp. 357-365 Development and Validation of Analytical Method for Fluconazole and Fluconazole Related Compounds (A, B, and C) in Capsule Formulations by
More informationReducing the risk of allergen contamination in the factory
Reducing the risk of allergen contamination in the factory Barbara Hirst RSSL Sponsored by Reactions To Food ADVERSE REACTIONS TO FOOD GENERIC May occur in anyone who consumes sufficient quantity of the
More informationIMPORTANT DISCLAIMER. Note
yn EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL June 2012 DRAFT GUIDANCE DOCUMENT FOR COMPETENT AUTHORITIES FOR THE CONTROL OF COMPLIANCE WITH EU LEGISLATION ON: Regulation (EU) No 1169/2011
More informationProf. Marina Heinonen University of Helsinki Member of the NDA Panel and EFSA s WG on Novel Foods
Guidance on Novel Foods Composition, production process and specification Prof. Marina Heinonen University of Helsinki Member of the NDA Panel and EFSA s WG on Novel Foods Info-Session 06 March 2017 Parma
More informationDevelopment and validation of stability indicating RP-LC method for estimation of calcium dobesilate in pharmaceutical formulations
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2016, 8 (11):236-242 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationKey Advantages of Comprehensive Cannabis Analysis
Comprehensive Cannabis Analysis: Pesticides, Aflatoxins, Terpenes, and High Linear Dynamic Range Potency from One Extract Using One Column and One Solvent System Robert Di Lorenzo 1, Diana Tran 2, KC Hyland
More informationCHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW
51 CHAPTER 2 SIMULTANEOUS ESTIMATION OF PIOGLITAZONE, GLIMEPIRIDE AND GLIMEPIRIDE IMPURITIES IN COMBINATION DRUG PRODUCT BY A VALIDATED STABILITY-INDICATING RP-HPLC METHOD 2.1 INTRODUCTION OF DOSAGE FORM
More informationJournal of Chemical and Pharmaceutical Research, 2018, 10(3): Research Article
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2018, 10(3):142-147 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Development of Reverse Phase HPLC Method and Validation
More informationResearch Article Simultaneous Estimation of DL-Methionine and Pyridoxine Hydrochloride in Tablet Dosage Form by RP-HPLC
Research Article Simultaneous Estimation of DL-Methionine and Pyridoxine Hydrochloride in Tablet Dosage Form by RP-HPLC Shinde Prashanti 1 *, Mane Aruna 2, Palled Mahesh 1, Bhat AR 1 and Karagane Swapna
More informationDevelopment and Validation of a Polysorbate 20 Assay in a Therapeutic Antibody Formulation by RP-HPLC and Charged Aerosol Detector (CAD)
LIFE SCIENCES AR ENOUGH? HOW DO YOU KNOW RAW MATERIALS ARE PURE? HOW DO YOU EVALUATE PRODUCT PACKAGING? HOW DO YOU DO YOU KNOW WHAT ANALYTICAL TECHNIQUE TO USE? HOW DO YOU SIMULTANEOUSLY TEST FOR TWO BYPRODUCTS?
More informationGeneral concepts in the Ph. Eur.: theory and rationale
General concepts in the Ph. Eur.: theory and rationale Cathie VIELLE Head of European Pharmacopoeia Department, EDQM / CoE 1 The structure of the Ph. Eur. General monographs Dosage form monographs General
More informationGeneral Concepts in the European Pharmacopoeia. Anne-Sophie Bouin European Pharmacopoeia Department, EDQM, Council of Europe
General Concepts in the European Pharmacopoeia Anne-Sophie Bouin European Pharmacopoeia Department, EDQM, Council of Europe General notices Anne-Sophie Bouin, 28/10/09 2009 EDQM, Council of Europe, All
More informationDevelopment and Validation for Simultaneous Estimation of Sitagliptin and Metformin in Pharmaceutical Dosage Form using RP-HPLC Method
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.5, No.4, pp 1736-1744, Oct-Dec 2013 Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin
More informationCurrent Developments in Guidance for Regulatory Bioanalysis
Current Developments in Guidance for Regulatory Bioanalysis Dr Gerry McGuire Resolution Analytical Consultancy Ltd Edinburgh, Scotland UK gerry@resolutioneurope.com 1st MENA Regulatory Conference on Bioequivalence,
More informationJournal of Chemical and Pharmaceutical Research
Available on line www.jocpr.com Journal of Chemical and Pharmaceutical Research ISSN No: 0975-7384 CODEN(USA): JCPRC5 J. Chem. Pharm. Res., 2011, 3(1):138-144 Simultaneous RP HPLC determination of Latanoprost
More informationAnalytical method validation for tablet of phenoxymethyl penicillin potassium by RP-HPLC method
Analytical method validation for tablet of phenoxymethyl penicillin potassium by RP-HPLC method Baghel U.S.* 1, Singhal M. 2, Gupta M.M. 1, Singh H.P. 3, Dave Shuchi 4, Sahu M. *1 Jaipur College of Pharmacy,
More informationAsian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:
Research Article CODEN: AJPAD7 ISSN: 2321-0923 Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page: www.ajpamc.com ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF GEFITINIB
More informationUSP <232> and <233> Understanding Your Path to Compliance with the New Elemental Impurity Chapters. Steve Wall Agilent Technologies
USP and Understanding Your Path to Compliance with the New Elemental Impurity Chapters Steve Wall Agilent Technologies Outline, USP - USP Chapter - Chapter Limits -
More informationReference Standards in the Analysis of Botanicals
Reference Standards in the Analysis of Botanicals Gabriel I Giancaspro, Ph.D. VP Foods, Dietary Supplements and Herbal Medicines Global Sciences and Standards Division Challenges with Botanical Reference
More informationHumco Compounding, 313 East 12th Street, Suite 230, Austin, TX 78701, USA; Tel.:
Chromatography 2015, 2, 642-654; doi:10.3390/chromatography2040642 OPEN ACCESS chromatography ISSN 2227-9075 www.mdpi.com/journal/chromatography Technical Note Simultaneous High Performance Liquid Chromatography
More informationDevelopment and validation of liquid chromatographic method for trazodone hydrochloride
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2012, 4 (6):1657-1664 (http://scholarsresearchlibrary.com/archive.html) ISS 0975-5071 USA CODE: DPLEB4
More informationIs it Method Verification or Validation, or Just Semantics? Michael Brodsky Brodsky Consultants
Is it Method Verification or Validation, or Just Semantics? Michael Brodsky Brodsky Consultants mhbrodsky@rogers.com Objectives To define and differentiate method validation from verification Consider
More informationQuantitative Method for Amphetamines, Phentermine, and Designer Stimulants Using an Agilent 6430 LC/MS/MS
Quantitative Method for Amphetamines, Phentermine, and Designer Stimulants Using an Agilent 6430 LC/MS/MS Application Note Forensic Toxicology Authors Jason Hudson, Ph.D., James Hutchings, Ph.D., and Rebecca
More informationJ Pharm Sci Bioscientific Res (4): ISSN NO
Development and Validation of Analytical Methods for Simultaneous Estimation of Pregabalin and Amitriptyline Hydrochloride in their Combined Marketed Dosage form ABSTRACT: Nikhilkumar Patel, Gurjit Kaur,
More informationDEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF LACOSAMIDE IN BULK AND ITS PHARMACEUTICAL FORMULATION
http://www.rasayanjournal.com Vol.4, No.3 (2011), 666-672 ISSN: 0974-1496 CODEN: RJCABP DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR IN BULK AND ITS PHARMACEUTICAL FORMULATION V.Kalyan Chakravarthy*
More informationTentu Nageswara Rao et al. / Int. Res J Pharm. App Sci., 2012; 2(4): 35-40
International Research Journal of Pharmaceutical and Applied Sciences Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2012; 2(4):35-40 Research Article Estimation of Fesoterodine fumarate
More informationSavesta Herbals is engaged in manufacturing
Savesta Herbals is engaged in manufacturing standardized herbal extracts that synergistically combine the ancient wisdom of Ayurveda with the modern production and QC methods. Our state-of- the- art production
More informationCHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW
132 CHAPTER 6 DEVELOPMENT AND VALIDATION OF A STABILITY-INDICATING RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION OF PARACETAMOL, TRAMADOL HYDROCHLORIDE AND DOMPERIDONE IN A COMBINED DOSAGE FORM 6.1 INTRODUCTION
More informationAvailable online at Scholars Research Library
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2015, 7 (3):157-161 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationMeasuring Lipid Composition LC-MS/MS
Project: Measuring Lipid Composition LC-MS/MS Verification of expected lipid composition in nanomedical controlled release systems by liquid chromatography tandem mass spectrometry AUTHORED BY: DATE: Sven
More informationPelagia Research Library
Available online at www.pelagiaresearchlibrary.com Der Pharmacia Sinica, 2014, 5(5):91-98 ISSN: 0976-8688 CODEN (USA): PSHIBD A novel RP-HPLC method development and validation of Perindopril Erbumine in
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)
European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use London, 21 September 2006 EMEA/CHMP/BWP/298390/2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON
More information10 Kadam V. N. et al. Ijppr.Human, 2014; Vol. 1(2): 10-21 (Research Article) DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF VOGLIBOSE, GLIMEPIRIDE AND METFORMIN HYDROCHLORIDE
More informationMEDAK DIST. ANDHRA PRADESH STATE, INDIA. Research Article RECEIVED ON ACCEPTED ON
Page67 Available Online through IJPBS Volume 1 Issue 2 APRIL- JUNE 2011 SIMPLE QUANTITATIVE METHOD DEVELOPMENT AND VALIDATION OF VALSARTAN IN PUREFORM AND PHARMACEUTICAL DOSAGE FORMS BYUV SPECTROSCOPY
More informationDevelopment and Validation of Multiresidue Pesticide Methods at FDA/CFSAN
Development and Validation of Multiresidue Pesticide Methods at FDA/CFSAN Jon W. Wong U.S. Food and Drug Administration Center for Food Safety and Applied Nutrition American Council of Independent Laboratories
More informationDevelopment and validation of related substances method for Varenicline and its impurities
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2016, 8 (1):304-309 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationDevelopment and Validation of a Simultaneous HPLC Method for Quantification of Amlodipine Besylate and Metoprolol Tartrate in Tablets
Journal of PharmaSciTech 0; ():- Research Article Development and Validation of a Simultaneous HPLC Method for Quantification of Amlodipine Besylate and Metoprolol Tartrate in Tablets * Sayyed Hussain,
More informationScholars Research Library
Available online at www.derpharmachemica.com Scholars Research Library Der Pharma Chemica, 2010, 2(5): 46-52 (http://derpharmachemica.com/archive.html) ISSN 0975-413X CODEN (USA): PCHHAX Development and
More informationPelagia Research Library
Available online at www.pelagiaresearchlibrary.com Der Pharmacia Sinica, 2015, 6(1):6-10 ISSN: 0976-8688 CODEN (USA): PSHIBD Validated RP-HPLC method for simultaneous estimation of metformin hydrochloride
More informationScholars Research Library
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2010, 2(2): 294-299 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More information36 J App Pharm Vol. 6; Issue 1: 36-42; January, 2014 Rao et al., 2014
36 J App Pharm Vol. 6; Issue 1: 36-42; January, 2014 Rao et al., 2014 Original Research Article SIMPLE AND RAPID LIQUID CHROMATOGRAPHIC METHOD FOR REAL-TIME QUANTIFICATION OF NAPROXEN / ESOMEPRAZOLE MAGNESIUM
More informationDeveloping Bioanalytical Methods Balancing the Statistical Tightrope
Developing Bioanalytical Methods Balancing the Statistical Tightrope Lee: can I use this number? Process Development GSK, 1997 2 it s about 40 about 40? probably... 3 Enlightenment? 5 Unconscious Conscious
More informationH e r b a l M e dicines' Q U A L I T Y M ANUAL. I. Introduction
INTRODUCTION To the Recommendation by the Board of the Eurasian Economic Commission Dated 20 No H e r b a l M e dicines' Q U A L I T Y M ANUAL I. Introduction 1. The Herbal Medicines Quality Manual (hereinafter
More informationHyderabad, India. Department of Pharmaceutical Chemistry, Glocal University, Saharanpur, India.
International Journal On Engineering Technology and Sciences IJETS RP-HPLC Method development and validation for the Simultaneous Estimation of Metformin and Empagliflozine in Tablet Dosage Form Shaik
More informationDEVELOPMENT AND VALIDATION OF RP-HPLC METHOD ESTIMATION OF TOLVAPTAN IN BULK PHARMACEUTICAL FORMULATION
http://www.rasayanjournal.com Vol.4, No.1 (2011), 165-171 ISSN: 0974-1496 CODEN: RJCABP DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR AND ITS PHARMACEUTICAL FORMULATION V. Kalyana Chakravarthy * and
More informationA Stronger Start to Every Workout
XSURGE A Stronger Start to Every Workout It happens all the time: athletes get into a great workout or training routine and suddenly, their performance starts to decline. Fatigue sets in. Muscle soreness
More informationJournal of Pharmacreations
Journal of Pharmacreations ISSN: 2348-6295 Pharmacreations Vol.5 Issue 1 Jan- Mar- 2018 Journal Home page: www.pharmacreations.com Research article Open Access Method development and validation of apixaban
More informationThe New 6495 Triple Quadrupole LC/MS
The New 6495 Triple Quadrupole LC/MS Experience A New Level of Confidence Martin Haex Product Specialist MS and Automation 1 Overview of Topics The New 6495 QQQ LC/MS Technology Innovations Quantitation
More informationComparison of conventional HPLC with UPLC method for determination of albuterol sulfate and it s impurities in pharmaceutical formulation
Oriental Journal of Chemistry Vol. 24(2), 537-544 (2008) Comparison of conventional HPLC with UPLC method for determination of albuterol sulfate and it s impurities in pharmaceutical formulation P.N. DALVI,
More informationApplication Note. Small Molecule Pharmaceuticals. 2-Ethyl-2-phenylmalonamide Ethosuximide Primidone Carbamazepine. Carbamazepine-
Analysis of Pharmaceutical Substances Using HPLC and UHPLC Methods Backward Compatibility for Validated Analytical Procedures and Methods Comparing the Infi nity LC and the Infi nity II LC Application
More informationAnalysis of Counterfeit Antidiabetic Drugs by UHPLC with the Agilent 1220 Infinity Mobile LC
Analysis of Counterfeit Antidiabetic Drugs by UPLC with the Agilent 1 Infinity Mobile LC Application Note Small Molecule Pharmaceuticals & Generics Author Sonja Schneider Agilent Technologies, Inc. Waldbronn,
More informationIrena Vovk 1, Breda Simonovska 1, Danica Agbaba 2 and Gordana Popović 2
Lutein in food supplements Irena Vovk 1, Breda Simonovska 1, Danica Agbaba 2 and Gordana Popović 2 1 National Institute of Chemistry, Ljubljana, Slovenia 2 University of Belgrade, Faculty of Pharmacy Why
More informationUSP Dietary Supplements Standards Up-to-Date Roundtable Meeting Report. Huy Dinh, MS. Senior Scientific Liaison Dietary Supplements
1 USP Dietary Supplements Standards Up-to-Date Roundtable Meeting Report Huy Dinh, MS. Senior Scientific Liaison Dietary Supplements Roundtable s objectives Foster discussion among the participants to
More informationSimultaneous estimation of Metformin HCl and Sitagliptin in drug substance and drug products by RP-HPLC method
International Journal of Chemical and Pharmaceutical Sciences 2017, Mar., Vol. 8 (1) ISSN: 0976-9390 IJCPS Simultaneous estimation of Metformin HCl and Sitagliptin in drug substance and drug products by
More informationMULTI-COMPONENT ANALYSIS OF HEAVY METALS
MULTI-COMPONENT ANALYSIS OF HEAVY METALS in Various Foods Using Shimadzu s AA, ICP, ICPMS & EDX HEAVY METALS TESTING HEAVY METALS POSE A SIGNIFICANT THREAT TO HUMAN HEALTH The U.S. Food and Drug Administration
More informationAnalytical methods and laboratory choice for food composition, an introduction
Analytical methods and laboratory choice for food composition, an introduction Paul Hulshof, Global challenges Research Fund Foodomp workshop, Pretoria, 5-9 Feb, 2018 General Reasons for analyzing food
More informationDevelopment and Validation of Improved RP-HPLC method for Identification and Estimation of Ellagic and Gallic acid in Triphala churna
International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 0974-4290 Vol.2, No.3, pp 1486-1493, July-Sept 2010 Development and Validation of Improved RP-HPLC method for Identification and Estimation
More informationDevelopment and Validation of Stability Indicating HPTLC Method for Estimation of Seratrodast
ARC Journal of Pharmaceutical Sciences (AJPS) Volume 2, Issue 3, 2016, PP 15-20 ISSN 2455-1538 DOI: http://dx.doi.org/10.20431/2455-1538.0203004 www.arcjournals.org Development and Validation of Stability
More informationGUIDANCE FOR THE ACCREDITATION OF GENERIC METHODS & METHODS OF FLEXIBLE SCOPE OF DETERMINATION OF METALS IN FOODS
GUIDANCE FOR THE ACCREDITATION OF GENERIC METHODS & METHODS OF FLEXIBLE SCOPE OF DETERMINATION OF METALS IN FOODS ESYD G-METALS/01/01/20-10-2016 1/6 ESYD G-METALS Issue: 01 Revision: 01 Issue Date: 24-10-2008
More informationStress Degradation Studies And Validation Method For Quantification Of Aprepitent In Formulations By Using RP-HPLC
International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 0974-4290 Vol.5, No.4, pp 1462-1468, April-June 2013 Stress Degradation Studies And Validation Method For Quantification Of Aprepitent
More informationMALAYSIAN MALAYSIAN COCOA WORKSHOP ON THE SAFE USE OF PESTICIDES IN COCOA AND HARMONIZED
COCOA WORKSHOP ON THE SAFE USE OF PESTICIDES IN COCOA AND HARMONIZED Pesticides - Commonly used in cocoa production Residue problems - health hazard GAP & Legislation CODEX Alimentarius - introduced and
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES REPORT FROM THE COMMISSION TO THE COUNCIL AND THE EUROPEAN PARLIAMENT
EN EN EN COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 5.12.2008 COM(2008) 824 final REPORT FROM THE COMMISSION TO THE COUNCIL AND THE EUROPEAN PARLIAMENT on the use of substances other than vitamins
More informationApplication Note Ginseng for Ginsenosides by HPLC. Botanical Name: Common Names:
Application Note 0048 - Ginseng for Ginsenosides by PLC As published in The andbook of Analytical Methods for Dietary Supplements Botanical Name: Common Names: Panax ginseng; Panax quinquefolium American
More informationJournal of Chemical and Pharmaceutical Research, 2017, 9(9): Research Article
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2017, 9(9):70-80 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Development and Validation of Stability Indicating
More information2. Review of literature: 2.1 General review on methods of simultaneous determination of hypertensive drugs.
2. Review of literature: 2.1 General review on methods of simultaneous determination of hypertensive drugs. Still present many analytical methods are available on traditional or classical methods and these
More informationMedicinal Marihuana Science, Redefined
Medicinal Marihuana Science, Redefined From Concept to Commercialization.... www.avantirx.com WELL BEYOND COMPLIANCE Medicinal Marihuana Science, Redefined... ARA Avanti Rx Analytics Inc. is a Health Canada
More informationInternational Journal of Pharma and Bio Sciences
International Journal of Pharma and Bio Sciences RESEARCH ARTICLE PHARMACEUTICAL ANALYSIS DEVELOPMENT AND VALIDATION OF LIQUID CHROMATOGRAPHIC METHOD FOR ESTIMATION OF ESCITALOPRAM OXALATE IN TABLET DOSAGE
More informationForensic and clinical products and services
r o i d s N a t u r a l p r o d u c t s T D M Forensic and clinical products and services R e f e r e n c e s t a n d a r d s F o r e n s i c a n d c l i n i c a l t o x i c o l o g y S t a b l e i s o
More informationVitamin D Metabolite Analysis in Biological Samples Using Agilent Captiva EMR Lipid
Vitamin D Metabolite Analysis in Biological Samples Using Agilent Captiva EMR Lipid Application Note Clinical Research Authors Derick Lucas and Limian Zhao Agilent Technologies, Inc. Abstract Lipids from
More informationAKA Good Manufacturing Practice (GMP) Certification Program
AKA Good Manufacturing Practice (GMP) Certification Program Preamble The American Kratom Association (AKA) is establishing this program to assure the safety and integrity of kratom dietary supplements
More informationSUMMARY, CONCLUSION & RECOMMENDATIONS
196 Chapter-5 SUMMARY, CONCLUSION & RECOMMENDATIONS 197 CHAPTER 5 5.1 Summary, Conclusion and Recommendations Summary and Conclusion are drawn based on the work carried out by the author on development
More informationAvailable online Research Article
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2016, 8(1):171-176 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Reverse phase high performance liquid chromatography
More informationDr. Christian Zeine LGC Standards GmbH. Webinar Series 2013 July 2013
The 7 truths of impurities and their reference standards FDA's and other regulators' viewpoints and further stories (Part 1) Dr. Christian Zeine LGC Standards GmbH Webinar Series 2013 July 2013 Quick guide
More informationImpurity Profiling of Carbamazepine by HPLC/UV
Application Note: 52049 Impurity Profiling of Carbamazepine by HPLC/UV Terry Zhang, Guifeng Jiang, Thermo Fisher Scientific, San Jose, CA, USA Key Words Accela Hypersil GOLD Carbamazepine Drug Analysis
More informationGuideline on quality of herbal medicinal products 1 /traditional herbal medicinal products
31 March 2011 Committee for Medicinal Products for Human Use (CHMP) Committee for Medicinal Products for Veterinary Use (CVMP) Committee on Herbal Medicinal Products (HMPC) Guideline on quality of herbal
More informationMETHOD VALIDATION: WHY, HOW AND WHEN?
METHOD VALIDATION: WHY, HOW AND WHEN? Linear-Data Plotter a,b s y/x,r Regression Statistics mean SD,CV Distribution Statistics Comparison Plot Histogram Plot SD Calculator Bias SD Diff t Paired t-test
More informationMethod Development and Validation for Simultaneous Estimation of Atorvastatin and Ezetimibe in Pharmaceutical Dosage Form by HPLC
World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original
More informationScholars Research Library. Der Pharmacia Lettre, 2015, 7 (5):44-49 (
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2015, 7 (5):44-49 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationBias in clinical chemistry. Elvar Theodorsson EFLM and Linköping University
Bias in clinical chemistry Elvar Theodorsson EFLM and Linköping University Bias a controversial subject Different perspectives Reseachers Users Regulatory bodies Standardisation organisations Metrologists
More informationDevelopment and validation of UV-visible spectrophotometric method for estimation of rifapentine in bulk and dosage form
Available online at www.derpharmachemica.com Scholars Research Library Der Pharma Chemica, 2013, 5(2):251-255 (http://derpharmachemica.com/archive.html) ISSN 0975-413X CODEN (USA): PCHHAX Development and
More informationInternational Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:
Research Article CODEX: IJRPJK ISSN: 2319 9563 International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage: www.ijrpns.com HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS
More informationRP-HPLC Method for the Simultaneous Estimation of Sitagliptin Phosphate and Metformin Hydrochloride in Combined Tablet Dosage Forms
Est. 1984 ORIENTAL JOURNAL OF CHEMISTRY An International Open Free Access, Peer Reviewed Research Journal www.orientjchem.org ISSN: 0970-020 X CODEN: OJCHEG 2012, Vol. 28, No. (1): Pg. 463-469 RP-HPLC
More informationEPOCH ESSENTIAL OILS SCIENCE
EPOCH ESSENTIAL OILS SCIENCE A NATURAL PROGRESSION Developing essential oils at Nu Skin couldn t have been a more natural endeavor. Ever since Nu Skin acquired Pharmanex in 1998, we have been combining
More informationTopics covered by the talk
04/02/2016 Finished product monographs containing chemically defined active substances Dr Dirk Leutner Scientific Officer, European Pharmacopoeia Department European Directorate for the Quality of Medicines
More informationDETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS
FORENSICS AND TOXICOLOGY ANALYSIS DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS Solutions for Your Analytical Business Markets and Applications
More informationApplication Note. Agilent Application Solution Analysis of fat-soluble vitamins from food matrix for nutrition labeling. Abstract.
Agilent Application Solution Analysis of fat-soluble vitamins from food matrix for nutrition labeling Application Note Food 1 Agilent 12 Infinity 1 Author Siji Joseph Agilent Technologies, Inc. Bangalore,
More informationDIHYDROSTREPTOMYCIN and STREPTOMYCIN First draft prepared by Lynn G. Friedlander, Rockville, MD, USA Rainer W. Stephany, Bilthoven, The Netherlands
DIHYDROSTREPTOMYCIN and STREPTOMYCIN First draft prepared by Lynn G. Friedlander, Rockville, MD, USA Rainer W. Stephany, Bilthoven, The Netherlands ADDENDUM To the monograph and addenda prepared by the
More informationFig.1. Denatonium benzoate (DB) chemical structure
ILIADE code 280 CLEN Method Determination of Denatonium Benzoate in Alcoholic Products by HPLC-UV 1 Scope The purpose of this method is verification of fulfilment of the legislative requirements on denatured
More informationComparative study of analytical method development of fluconazole in tablets and capsule by ultraviolet spectrophotometric method
Research Article Comparative study of analytical method development of fluconazole in tablets and capsule by ultraviolet spectrophotometric method Shital S. Patil*, Ubhale Ravindra, Yeole Tejal, Tayade
More informationRP-HPLC Method Development and Validation of Abacavir Sulphate in Bulk and Tablet Dosage Form
RP-HPLC Method Development and Validation of Abacavir Sulphate in Bulk and Tablet Dosage Form S. LAVANYA* 1, SK. MANSURA BEGUM 1, K. NAGAMALLESWARA RAO 2, K. GAYATHRI DEVI 3 Department of pharmaceutical
More informationLC-MS/MS Method for the Determination of Tenofovir from Plasma
LC-MS/MS Method for the Determination of Tenofovir from Plasma Kimberly Phipps, Thermo Fisher Scientific, Runcorn, Cheshire, UK Application Note 687 Key Words SPE, SOLA CX, Hypersil GOLD, tenofovir Abstract
More informationAnalytical Method Development for USP Related Compounds in Paclitaxel Using an Agilent Poroshell 120 PFP
Analytical Method Development for USP Related Compounds in Paclitaxel Using an Agilent Poroshell 1 PFP Application Note Clinical Research Author Rongjie Fu Agilent Technologies (Shanghai) Co. Ltd Abstract
More information